Vaxxas, a clinical-stage biotechnology company, today announced it has completed enrollment for its Phase I clinical trial of a vaccine against an avian influenza A (H7N9) virus with pandemic ...

Regeneron initiated a quarterly dividend per share that looks somewhat attractive. Despite some recent issues, the biotech ...

India needs a transparent, institutional mechanism to look at both the short and long-term implications of tariffs. A nation ...

Mitsubishi Electric has reached an agreement with HD Renewable Energy to collaborate on projects aimed at achieving carbon ...

Amazon recently reported its fourth-quarter results, with sales rising 10% to $187.8 billion and earnings per share up 54% to ...

Home Depot's recent acquisitions raise concerns about management's capital discipline. Read why I recommend investors ...

Key Insights Home Depot's estimated fair value is US$408 based on 2 Stage Free Cash Flow to Equity With US$410 ...

DS Investment Securities noted on the 14th that the stock price of HD Hyundai Construction Equipment rose sharply due to ...

The market views HD Hyundai as having sufficient capacity to engage in asset management and acquisitions in the trillions of ...